The antiatherogenic effect of nifedipine on intramural small coronary arterial lesions in cholesterol-fed rabbits

Angiology. 1998 Jan;49(1):49-54. doi: 10.1177/000331979804900106.

Abstract

The objective of this study was to examine the suppressive effect of nifedipine on intramural coronary arterial lesions in cholesterol-fed rabbits. Each rabbit in Groups A (n=6) and B (n=5) was fed a 0.3% cholesterol diet and was orally administered nifedipine (40 mg/day) or placebo. Each rabbit in Groups C (n=5) and D (n=6) was fed a 0.5% cholesterol diet and was orally administered nifedipine (40 mg/day) or placebo. The serum concentrations of total cholesterol (TC) were determined at 1-week intervals to calculate the integrated values. The lesion induction ratio was defined as the ratio of intramural coronary arteries 50-150 microm in diameter with arterial lipoidosis to the total number of arteries of the same diameter. There were no significant differences between the nifedipine-treated and placebo groups in either the integrated TC or lesion induction ratio in either the 0.3% and 0.5% cholesterol-fed rabbits. This study demonstrates that nifedipine does not suppress atherogenesis in the intramural small coronary arteries of cholesterol-fed rabbits.

MeSH terms

  • Administration, Oral
  • Animals
  • Calcium Channel Blockers / administration & dosage
  • Calcium Channel Blockers / therapeutic use*
  • Cholesterol / blood
  • Cholesterol, Dietary / administration & dosage
  • Cholesterol, Dietary / adverse effects*
  • Coronary Artery Disease / drug therapy
  • Coronary Artery Disease / pathology
  • Coronary Disease / drug therapy*
  • Coronary Disease / pathology
  • Coronary Vessels / drug effects*
  • Coronary Vessels / pathology
  • Diet, Atherogenic
  • Hypercholesterolemia / drug therapy
  • Hypercholesterolemia / pathology
  • Hypolipidemic Agents / administration & dosage
  • Hypolipidemic Agents / therapeutic use*
  • Male
  • Microcirculation / pathology
  • Nifedipine / administration & dosage
  • Nifedipine / therapeutic use*
  • Placebos
  • Rabbits
  • Random Allocation
  • Treatment Failure

Substances

  • Calcium Channel Blockers
  • Cholesterol, Dietary
  • Hypolipidemic Agents
  • Placebos
  • Cholesterol
  • Nifedipine